Based on previous publications showing PASP ≥35 mmHg to be significantly correlated with increased mortality in patients with chronic kidney disease/ESRD, we divided our study population into 2 groups: group 1 with PASP <35 mmHg and group 2 with PASP ≥35 mmHg [16–19].
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.